Aardvark Therapeutics Inc... (AARD)
NASDAQ: AARD
· Real-Time Price · USD
10.73
-0.53 (-4.71%)
At close: Aug 15, 2025, 1:15 PM
-4.71% (1D)
| Bid | 10.55 |
| Market Cap | 232.81M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -24.31M |
| EPS (ttm) | -1.69 |
| PE Ratio (ttm) | -6.35 |
| Forward PE | -4.57 |
| Analyst | Buy |
| Ask | 10.74 |
| Volume | 43,349 |
| Avg. Volume (20D) | 52,180 |
| Open | 11.38 |
| Previous Close | 11.26 |
| Day's Range | 10.25 - 11.38 |
| 52-Week Range | 4.88 - 19.58 |
| Beta | 2.82 |
About AARD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol AARD
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for AARD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 day ago
+11.55%
Aardvark Therapeutics shares are trading lower aft...
Unlock content with
Pro Subscription
4 months ago
+10.39%
Aardvark Therapeutics shares are trading higher after RBC Capital and Cantor Fitzgerald reiterated their respective ratings on the stock and maintained their price targets.
